Jobs Numbers

The headline numbers are in, and they seem favorable enough: unemployment has dropped to 5.9%, and 248,000 new jobs were created in September.

However.

Counting the 142,000 new jobs created in August, new jobs were created at a monthly average of 195,000 jobs per month over the total interval. Using, instead, Labor’s revised August number of 180,000 new jobs (I’d be curious to learn how President Barack Obama’s Labor Department could make such a large estimation error—a 20% error), that still works out to a pretty anemic 214,000 new jobs per month over the period.

The labor force participation rate, at 62.7%, remains at historic lows. If this rate were at 2007’s level of 66.2% (a rough average for the year), the unemployment would be nearly 11%.

Even taking the 5.9% unemployment rate as legitimate, we’re still years behind schedule—not just behind the rate extant at this point in a normal recovery, but behind Obama’s promised unemployment rate which he used to sell his Stimulus package, as this graph illustrates.ObamaPromisedEmploymentRate

In particular, we’re still not at the 5% Obama promised we’d reach by last year. Oh, and that peak unemployment of 8% worked out to over 10%, which was worse than the No-Stimulus situation which he projected.

Additionally, median income remains down sharply from pre-Panic levels—7.9% sharply.

Additionally, new jobs created since the Panic officially ended in 2009 has only just, this past summer, matched the number of jobs extant in 2007, some three or more years later than prior recoveries. And that…milestone…ignores the fact that there are, today, 16 million more Americans in the civilian noninstitutional population (able-bodied Americans, capable of working) than there were just prior to the Panic.

What’s different between this recovery and the recoveries from prior recessions? Only Obama’s policies, actively aided and abetted by his pet, Senate Majority Leader Harry Reid (D, NV) and the latter’s Senate cohorts. All the prior recoveries proceeded much faster, and those paces occurred under both Republican and Democrat administrations.

Another VA Problem

This one, though, isn’t primarily the Veterans Affair’s doing.

Veterans at the Shreveport, LA, Veterans Administration hospital have been going without toothbrushes, toothpaste, pajamas, sheets, and blankets while department officials spend money on new Canadian-made furniture, televisions to run public service announcements and solar panels….

Some specifics:

According to the VA, the department spent $74,412 on 24 flat screen TVs for “patient/employee information”—one 50 inches wide and the others 42 inches. The furniture cost $134,082, and the solar project was approximately $3 million.

This is shameful, but this falls on Congress. Under Federal funding rules, capital equipment—the TVs, solar, etc—fall into one funding category, and supplies—toothbrushes and paste, blankets, etc—fall into a separate category. Under those same rules, the VA (and any other agency whose funding falls into different categories) cannot take funds from, say, capital equipment, and spend it on, say, supplies. It gets even more bureaucratic than that. Agencies can’t reallocate capital expenses from one capital item to another: the VA can’t, for instance, take some of those $3 million from solar and buy more TVs with it. Only Congress can authorize such reallocations.

No, Congress must answer for this misallocation. That it’s what the VA asked for in its budget request may be true, but Congress—that collection of our directly elected representatives—isn’t supposed to be a rubber stamp for every request for money that wanders by. It’s our money Congress is allocating, not Congress’ and not the VA’s.

It’s true enough that the VA could have—should have—gone to Congress and asked for a reallocation on recognition of the supply funding shortfall. That it seems not to have is an internal VA problem that supports my argument for disbanding the VA and using the budget to fund vouchers sent directly to our veterans.

There are other problems described at the Watchdog.org link above that are entirely within the VA’s ability to correct, but this one is not.

Obamacare and Health Care

As Dr Scott Atlas, of Stanford University’s Hoover Institution, in a recent The Wall Street Journal op-ed noted,

  • Private company medical innovation R&D spending in the US the last three years averaged 2.1%, down from an average of 6% over the previous fifteen
  • Malaysia, Thailand, Singapore, South Korea, India, and the EU had greater R&D spending growth in the same period
  • The PRC had a growth rate of 22%

Certainly, those other polities, the EU excepted, were starting from a much smaller base, and so their growth rates will tend to be exaggerated. Certainly, too, our own historically weak economy is exacerbating the situation.

All that notwithstanding, though, this is a trend that is allowed to continue at the peril of our leadership in things medical. Obamacare, with its removal of the insurance aspect of health plans, actively hurts this. What plan can pay for the latest and best drugs or devices, and so drive innovation—or even those drugs or devices that are merely near the cutting edge, or that are middle tier—when those plans aren’t allowed to recoup their costs, except at generalized taxpayer expense?

There’s one aspect, though, that is a direct assault on medical innovation, and that’s Obamacare’s medical-device excise tax. This is a tax the takes 2.3% off the top—that is, before expenses and profit—of all medical device sales. This includes devices from heart pace makers to dialysis units to bandages sold in bulk to hospitals.

2.3% is no big deal?

  • Johnson & Johnson’s medical device and diagnostic sales were down 1.5% in the US, versus up 1.8% internationally, in the first half of 2014
  • General Electric reported that the US healthcare sales shrank by 2% in the second quarter, versus up 2% in Europe
  • Medtronic’s US sales for the 2014 fiscal year were up 1.7%, versus 5.9% internationally
  • Baxter reported US sales of medical products were down 15% for the quarter ended June 2014, versus up 8% globally
  • Fresenius’ US sales of dialysis products were down 1.2% in the first half of 2014, versus up 0.6% internationally

And (via the first link above)

Boston Scientific, Stryker, and Cook Medical have announced job cuts and plans to open new centers for R&D, manufacturing, and clinical trials overseas.

And so on.

Many attempts have been made to repeal this pernicious tax, the latest this past summer. The Democrat-controlled Senate refused to consider it. Again.

PRC, Hong Kong, and Rights

The situation in Hong Kong, which the People’s Republic of China has created with its high-handed treatment of the Special Administrative Region, is getting tighter.

[Chief Executive Leung Chun-ying] Leung told voters it is better to agree to Beijing’s plans for nominating candidates and to hold an election, than to stick with the current system of having an Election Commission choose the chief executive.

“It is definitely better to have universal suffrage than not,” Leung said. “It is definitely better to have the chief executive elected by 5 million eligible voters than by 1,200 people. And it is definitely better to cast your vote at the polling station than to stay home and watch on television the 1,200 members of the Election Committee cast their votes.”

This is cynically misleading. The 1,200 to whom Leung referred are the nominating committee of the Communist Party of China. They’ve been the ones—and they continue to be the ones, now formally under the control of the Party’s Standing Committee—who will determine who the candidates will be that those “5 million eligible voters” can select from. Those 5 million are only being allowed to rubber stamp the selection made by those 1,200. This is no elective choice. Of course, Leung and his PRC masters know this.

And

[PRC President] Xi Jinping, who has taken a hard line against any perceived threat to the Communist Party’s hold on power, vowed in a National Day speech to “steadfastly safeguard” Hong Kong’s prosperity and stability.

This is just wind in the trees. Xi knows full well that Beijing cannot “steadfastly safeguard” Hong Kong’s prosperity and stability. Only the people of Hong Kong, acting for and by themselves, without outside interference, can do that.

And

China’s government…so far it has not overtly intervened, leaving Hong Kong authorities to handle the crisis.

This is a misunderstanding. The Hong Kong authorities are in the streets, not in the government buildings. The people are sovereign over their government in a free state. Of course, this is hard to realize from inside a despotic state.

The protesters, upset that Chief Executive Leung Chun-ying has refused to meet them, have threatened to expand their demonstrations unless he resigns and the Chinese leadership agrees to broader electoral reforms.

It’s clear from the breadth of these protests, that the PRC has lost the consent of the Hong Kong-ese to govern them. PRC governance, thus, is illegitimate. This is corroborated by the protest news clampdown the PRC has done, especially in contrast to the freely flowing protest news within Hong Kong.

And finally, there’s this failure, this one from the West.

British Prime Minister David Cameron saying he planned to summon the Chinese ambassador to discuss the dispute, saying it is essential that Hong Kong’s people have a genuine right to choose their top leader.

This is an even greater misunderstanding, both by its existence and coming as it does from the leader of the birthplace of John Locke. No, Prime Minister, each one of Hong Kong’s people is created with an inalienable right to his own liberty and happiness. That means he has an inalienable right to choose his own government and the men who operate it. What is essential is that Hong Kong’s people have that right genuinely acknowledged and accepted.

In Which another Federal Judge Gets it Right

Recall Halbig v Sebelius, the case wherein plaintiffs objected to subsidies being paid to Obamacare plan purchasers when the those plans were bought through ObamaMart, the Federally run health plan exchange, instead of through State-run health plan exchanges. The text of the Obamacare law allows the latter and bars the former. The DC Circuit agreed with plaintiffs and struck down the subsidies. (The current status of that ruling is that it’s been stayed pending review of Halbig by the DC Circuit sitting en banc.)

US District Judge Ronald White, of the Eastern District of Oklahoma, has ruled on a similar case that came up in his district, a part of the 10th Circuit. I won’t go into the specifics of Pruitt v Burwell, White’s case; the cases are very similar, and the point I want to make here is slightly different, anyway. I will note that plaintiff Pruitt is Oklahoma Attorney General Scott Pruitt, and defendant Burwell is Sylvia Mathews Burwell, HHS Secretary (sitting in for Kathleen Sebelius under an arcane Federal rule that allows such things). I will note further that Treasury Secretary Jacob Lew also was a defendant in this case, and leave things there.

White ruled for the plaintiff, which means he also held that the subsidies paid to Obamacare plan purchasers who bought them through ObamaMart are illegal.

Here’s where things get interesting.

In his conclusion, White wrote [citations omitted, emphasis mine]

Other judges in similar litigation have cast the plaintiffs’ argument in apocalyptic language. The first sentence of Judge Edwards’ dissent in Halbig is as follows: “This case is about Appellants’ not-so-veiled attempt to gut the Patient Protection and Affordable Care Act (‘ACA’).” Concurring in King, Judge Davis states that “[appellants’ approach would effectively destroy the statute….” Further, “[w]hat [appellants] may not do is rely on our help to deny to millions of Americans desperately-needed health insurance….”

And

Of course, a proper legal decision is not a matter of the court “helping” one side or the other. A lawsuit challenging a federal regulation is a commonplace occurrence in this country, not an affront to judicial dignity. A higher-profile case results in greater scrutiny of the decision, which is understandable and appropriate. “[H]igh as those stakes are, the principle of legislative supremacy that guides us is higher still…. This limited role serves democratic interests by ensuring that policy is made by elected, politically accountable representatives, not by appointed life-tenured judges.”

And

This is a case of statutory interpretation. “The text is what it is, no matter which side benefits.” Such a case (even if affirmed on the inevitable appeal) does not “gut” or “destroy” anything. On the contrary, the court is upholding the Act as written. Congress is free to amend the ACA to provide for tax credits in both state and federal exchanges, if that is the legislative will. … “But in the last analysis, these always-fascinating policy discussions are beside the point. The role of this Court is to apply the statute as it is written – even if we think some other approach might ‘accor[d] with good policy.’“

Finally, quoting from a ruling by his own 10th Circuit appellate court,

In reviewing statutes, courts do not assume the language is imprecise…. Rather, we assume that in drafting legislation, Congress says what it means.

And that’s the deal. A law says what Congress—the People’s directly elected representatives—says it says. A judge, or any appellate court at any level of our judicial hierarchy, can only apply that law to the case before him. Most especially, he cannot rewrite the law or “creatively interpret” it into something more agreeable to his personal philosophy.

Oh, and just to saucer and blow the thing, White formally ruled pretty clearly:

The court holds that the IRS Rule [allowing those subsidies] is arbitrary, capricious, an abuse of discretion or otherwise not in accordance with law, pursuant to 5 USC §706(2)(A), in excess of statutory jurisdiction, authority, or limitations, or short of statutory right, pursuant to 5 USC §706(2)(C), or otherwise is an invalid implementation of the ACA….

Judge White’s ruling can be seen here.

 

h/t Jonathan Keim of the National Review Online